Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3 
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth 
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO 
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars 
Hyundai Motor Union Launches First Full Strike in Decade Over Wages, AI Job Risks 
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits 
Coty Revenue Beats Estimates as Beauty Demand Holds Firm 
TikTok, DOJ Reach $400 Million Children’s Privacy Settlement 
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut 
REPAY Stock Rises After Visa Platform Connect Collaboration 
OpenAI Tightens AI Safety Monitoring After Security Incidents 
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut 
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports 
Barclays Downgrades Renault as Cost Savings Challenges Grow 
Amazon to Expand Drone Delivery to 500 U.S. Locations 
Alibaba Shares Fall as AI Spending Hits Profit 
Add as a preferred source on Google
Salt Lake City, UT. , May 08, 2018 -- Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-seven cents ($.27) per share of common stock payable on July 6, 2018 to shareholders of record at the close of business on June 15, 2018. This is a 2% increase over the dividend declared in the same quarter of the prior year.
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD’s website at www.utahmed.com.
Contact: Utah Medical Products, Inc. Crystal Rios (801) 566-1200
